Open AccessFDA Approvals for Revlimid for MCL and Xgeva for Giant Cell Tumor of the Bone
Author(s) -
AUTHOR_ID
Publication year - 2013
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000432329.52353.a9
Subject(s) - lenalidomide , medicine , multiple myeloma